“Advancing Your Career as a Woman in the Pharmaceutical/Chemical Industry” A short presentation followed by Q&A with speaker Dr. Anabella Villalobos, Neuroscience and Antibody Drug Conjugate Medicinal Chemistry, Pfizer.
On average, women represent a larger portion of today’s workforce yet still collect only a portion of their male counterpart’s salary for the same job. But a change is coming. The pharmaceutical industry has recognized that hiring women of a diverse culture provides a two-fold advantage – a skilled workforce and an insight into the diverse medical needs of the ethnic groups of its employees. Join our speaker, Anabella Villalobos as she shares her experience being a woman in the pharmaceutical/chemical industry.
Download Presentation Slides!
What You Will Learn
- Why is it important to tell your accomplishments
- Ask for what you want
- Seek high profile mentors
- And much more…
Date: Thursday, November 10, 2011
Time: 2:00-3:00 pm ET
Meet Your Experts
Anabella was born and raised in Panama City, Panama. She obtained her B.S. in Chemistry at the University of Panama and her Ph.D. in Medicinal Chemistry with Professor Lester A. Mitscher at the University of Kansas. She was a Fulbright-Hayes Fellow at the University of Kansas. After two years as a National Institutes of Health Postdoctoral Fellow with Professor Samuel Danishefsky at Yale University, Anabella joined the Groton Laboratories at Pfizer as a Research Scientist in the Neuroscience Medicinal Chemistry group in 1989. In June 2001, Anabella became the head of Neuroscience Medicinal Chemistry in Groton Discovery and in March 2007, she assumed responsibility for Antibacterials and Neuroscience Medicinal Chemistry. Following the October 2008 reorganization into therapeutic area research units, Anabella became the head of Neuroscience Medicinal Chemistry and assumed the Interim CSO role for the Neuroscience Research Unit leading biology and clinical efforts from October 2008 – October 2009 and March 2010 – August 2010. Anabella is currently the head of Neuroscience and Antibody Drug Conjugate Medicinal Chemistry. Among Anabella’s accomplishments are her contributions to the Acetylcholinesterase Inhibitor program leading to the design and discovery of CP-118,954 (icopezil) which was advanced to Phase II clinical trials in Alzheimer’s disease. This candidate became part of the agreement that led to the successful co-promotion of Aricept by Pfizer and Eisai. Anabella has significant drug discovery and development experience and has led multidisciplinary teams that have taken development candidates into Phase I and Phase II studies for Alzheimer’s disease, stroke, and sleep disorders. She is the author of multiple publications and patents. Anabella is married to Kevin C. Johnson and has two sons, Derek (20) and Casey (17). Derek is a junior in college and Casey is a senior in high school.
Teri Quinn Gray, is Six Sigma Consultant and New Product Commercialization Manager with DuPont Crop Protection in Newark, DE. She’s a native of Jackson, Mississippi and honors graduate of Jackson State University with a BS degree in chemistry. She holds a PhD in analytical chemistry from the University of Maryland, College Park and worked as NRC Postdoctoral Fellow at NIST in 1995-1997. She is President of the DE State Board of Education, appointed by Governor Jack Markell in June 2009. Teri currently serves on the ACS Women Chemists Committee and as chair of the ACS Diversity & Inclusion Advisory Board.
This episode of ACS Webinar is co-produced by the ACS Diversity Program. Learn more about diversity programs at http://www.acs.org/diversity.
The Fine Print
ACS Webinars™ does not endorse any products or services. The views expressed in this presentation are those of the presenters and do not necessarily reflect the views or policies of the American Chemical Society.